Cases & Deals

Nanobiotix completes €21.3 million private placement of new shares

Clients Nanobiotix SA

Jones Day advised Nanobiotix SA, an oncology focused nanomedicine company listed on the regulated market of Euronext in Paris, in connection with its €21.3 million (US$26.1 million) private placement of new shares to U.S. and European investors.